Indian pharmaceutical company Strides Pharma Science Ltd said on Thursday it has got regulatory approval to conduct clinical trials of antiviral drug favipiravir, considered a potential treatment for COVID-19. Via Times of India https://ift.tt/2hJjhqE
No comments:
Post a Comment